ABSCI CORP (ABSI) Stock Fundamental Analysis

NASDAQ:ABSI • US00091E1091

2.55 USD
+0.13 (+5.37%)
At close: Feb 13, 2026
2.6 USD
+0.05 (+1.96%)
After Hours: 2/13/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

ABSI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. While ABSI seems to be doing ok healthwise, there are quite some concerns on its profitability. ABSI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ABSI had negative earnings in the past year.
  • In the past year ABSI has reported a negative cash flow from operations.
  • ABSI had negative earnings in each of the past 5 years.
  • ABSI had a negative operating cash flow in each of the past 5 years.
ABSI Yearly Net Income VS EBIT VS OCF VS FCFABSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • ABSI has a Return On Assets (-46.78%) which is comparable to the rest of the industry.
  • ABSI has a Return On Equity of -54.49%. This is in the better half of the industry: ABSI outperforms 65.07% of its industry peers.
Industry RankSector Rank
ROA -46.78%
ROE -54.49%
ROIC N/A
ROA(3y)-43.94%
ROA(5y)-42.38%
ROE(3y)-52.85%
ROE(5y)-52.12%
ROIC(3y)N/A
ROIC(5y)N/A
ABSI Yearly ROA, ROE, ROICABSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ABSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABSI Yearly Profit, Operating, Gross MarginsABSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ABSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ABSI has more shares outstanding
  • Compared to 5 years ago, ABSI has more shares outstanding
  • ABSI has a better debt/assets ratio than last year.
ABSI Yearly Shares OutstandingABSI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ABSI Yearly Total Debt VS Total AssetsABSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 2.36 indicates that ABSI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.36, ABSI is in the better half of the industry, outperforming 67.18% of the companies in the same industry.
  • ABSI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ABSI (0.00) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.36
ROIC/WACCN/A
WACC8.65%
ABSI Yearly LT Debt VS Equity VS FCFABSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 5.89 indicates that ABSI has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 5.89, ABSI is in the better half of the industry, outperforming 61.61% of the companies in the same industry.
  • ABSI has a Quick Ratio of 5.89. This indicates that ABSI is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 5.89, ABSI is doing good in the industry, outperforming 62.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.89
Quick Ratio 5.89
ABSI Yearly Current Assets VS Current LiabilitesABSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.64% over the past year.
  • ABSI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.09%.
  • Measured over the past years, ABSI shows a quite strong growth in Revenue. The Revenue has been growing by 17.09% on average per year.
EPS 1Y (TTM)3.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)-33.09%
Revenue growth 3Y-1.75%
Revenue growth 5Y17.09%
Sales Q2Q%-77.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.23% on average over the next years. This is quite good.
  • Based on estimates for the next years, ABSI will show a very strong growth in Revenue. The Revenue will grow by 63.29% on average per year.
EPS Next Y8.18%
EPS Next 2Y11.08%
EPS Next 3Y11.19%
EPS Next 5Y12.23%
Revenue Next Year-18.65%
Revenue Next 2Y83.31%
Revenue Next 3Y79.19%
Revenue Next 5Y63.29%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABSI Yearly Revenue VS EstimatesABSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
ABSI Yearly EPS VS EstimatesABSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • ABSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ABSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABSI Price Earnings VS Forward Price EarningsABSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABSI Per share dataABSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.08%
EPS Next 3Y11.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ABSI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ABSCI CORP

NASDAQ:ABSI (2/13/2026, 8:00:00 PM)

After market: 2.6 +0.05 (+1.96%)

2.55

+0.13 (+5.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-16
Inst Owners66.04%
Inst Owner Change6.89%
Ins Owners6.25%
Ins Owner Change0.33%
Market Cap383.44M
Revenue(TTM)2.81M
Net Income(TTM)-114.60M
Analysts81.33
Price Target8.21 (221.96%)
Short Float %27.44%
Short Ratio10.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.81%
Min EPS beat(2)-10.99%
Max EPS beat(2)7.37%
EPS beat(4)2
Avg EPS beat(4)1.03%
Min EPS beat(4)-10.99%
Max EPS beat(4)10.49%
EPS beat(8)2
Avg EPS beat(8)-2.82%
EPS beat(12)3
Avg EPS beat(12)-7.95%
EPS beat(16)3
Avg EPS beat(16)-8%
Revenue beat(2)0
Avg Revenue beat(2)-66.07%
Min Revenue beat(2)-77.45%
Max Revenue beat(2)-54.7%
Revenue beat(4)0
Avg Revenue beat(4)-51.89%
Min Revenue beat(4)-77.45%
Max Revenue beat(4)-12.08%
Revenue beat(8)0
Avg Revenue beat(8)-46.62%
Revenue beat(12)1
Avg Revenue beat(12)-43.85%
Revenue beat(16)2
Avg Revenue beat(16)-38.63%
PT rev (1m)-2.56%
PT rev (3m)2.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)0%
EPS NY rev (3m)2.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-24.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 136.21
P/FCF N/A
P/OCF N/A
P/B 1.82
P/tB 2.28
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.02
BVpS1.4
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.78%
ROE -54.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-43.94%
ROA(5y)-42.38%
ROE(3y)-52.85%
ROE(5y)-52.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.15%
Cap/Sales 43.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.89
Quick Ratio 5.89
Altman-Z 2.36
F-Score3
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)44.41%
Cap/Depr(5y)179.67%
Cap/Sales(3y)101.78%
Cap/Sales(5y)229.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y8.18%
EPS Next 2Y11.08%
EPS Next 3Y11.19%
EPS Next 5Y12.23%
Revenue 1Y (TTM)-33.09%
Revenue growth 3Y-1.75%
Revenue growth 5Y17.09%
Sales Q2Q%-77.78%
Revenue Next Year-18.65%
Revenue Next 2Y83.31%
Revenue Next 3Y79.19%
Revenue Next 5Y63.29%
EBIT growth 1Y-15.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.25%
EBIT Next 3Y-18.87%
EBIT Next 5Y-3.11%
FCF growth 1Y-17.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.2%
OCF growth 3YN/A
OCF growth 5YN/A

ABSCI CORP / ABSI FAQ

What is the ChartMill fundamental rating of ABSCI CORP (ABSI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ABSI.


Can you provide the valuation status for ABSCI CORP?

ChartMill assigns a valuation rating of 0 / 10 to ABSCI CORP (ABSI). This can be considered as Overvalued.


How profitable is ABSCI CORP (ABSI) stock?

ABSCI CORP (ABSI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ABSI stock?

The Earnings per Share (EPS) of ABSCI CORP (ABSI) is expected to grow by 8.18% in the next year.